In mouse transplanted hearts, donor CCR2+ macrophages promote allograft rejection, whereas donor CCR2– macrophages promote allograft survival. These findings, published in Circulation, suggest that targeting the innate immune response of donor hearts might be beneficial for transplantation recipients.

Your institute does not have access to this article